Review delineates differences in clinical strategies between microcystic and macrocystic lymphatic malformations to guide ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy will begin a double-blind, randomized Phase 3 ...

Rapamycin and several analogs, such as CCI-779 and RAD001, are currently undergoing clinical evaluation as anticancer agents. In this study, we show that inhibition of mammalian target of rapamycin ...

Rapamycin is a drug used to suppress the immune system in transplant patients, but scientists have found that it may have another use. The drug has been shown to have anti-aging properties, despite no ...

Rapamycin, a complex macrolide and potent fungicide, immunosuppressant and anticancer agent, is a highly specific inhibitor of mammalian target of rapamycin (mTOR). Rapamycin has been shown to induce ...

Rapamycin has been trending on social media, where biohackers such as Dr. Peter Attia and Bryan Johnson tout it as the “gold standard” for people seeking to live a longer, healthier life. Rapamycin is ...

Liver resection for multifocal hepatocellular carcinoma. Background: PI3K/Akt/mTOR is a critical survival pathway in hepatocellular carcinoma (HCC) often correlated with poor prognosis. Rapamycin ...

The hype around the off-label use of the immunosuppressant rapamycin to prevent aging and increase longevity could be unfounded. This is the warning of researchers who have critically explored ...

Scientists at the Okinawa Institute of Science and Technology Graduate University (OIST) have taken one step closer to potential cures for several human genetic diseases, and the answers have been ...

Every time Hilary publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Every time Hilary publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...